902 related articles for article (PubMed ID: 7581095)
61. [Allogeneic bone marrow transplantation in a case of acute lymphoblastic leukemia with positive Philadelphia chromosome].
Kitoh T; Tabata Y; Akiyama Y; Kiriyama Y; Kubota M; Mikawa H
Rinsho Ketsueki; 1989 May; 30(5):680-5. PubMed ID: 2795882
[TBL] [Abstract][Full Text] [Related]
62. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
IMAHASHI N; TOKUNAGA M; NISHIWAKI S; YANAGISAWA M; OZAWA Y; MIYAMURA K
Rinsho Ketsueki; 2009 Nov; 50(11):1612-5. PubMed ID: 20009435
[TBL] [Abstract][Full Text] [Related]
63. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
64. Alternative donor bone marrow transplantation for children with juvenile myelomonocytic leukemia.
Bunin N; Saunders F; Leahey A; Doyle J; Calderwood S; Freedman MH
J Pediatr Hematol Oncol; 1999; 21(6):479-85. PubMed ID: 10598658
[TBL] [Abstract][Full Text] [Related]
65. Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation.
Granados E; de La Cámara R; Madero L; Díaz MA; Martín-Regueira P; Steegmann JL; Arranz R; Figuera A; Fernández-Rañada JM
Haematologica; 2000 Oct; 85(10):1060-7. PubMed ID: 11025598
[TBL] [Abstract][Full Text] [Related]
66. Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival.
Ringdén O; Aschan J; Boström L; Dahllöf G; Tollemar J; Paulin T; Gahrton G; Groth CG; Klaesson S; Lindquist R
Clin Transpl; 1990; ():175-87. PubMed ID: 2103143
[TBL] [Abstract][Full Text] [Related]
67. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
[TBL] [Abstract][Full Text] [Related]
68. Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.
Toubai T; Tanaka J; Mori A; Hashino S; Kobayashi S; Ota S; Miura Y; Kato N; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Toyoshima N; Asaka M; Imamura M
Clin Transplant; 2004 Oct; 18(5):552-7. PubMed ID: 15344959
[TBL] [Abstract][Full Text] [Related]
69. [Allogeneic bone marrow transplantation in the treatment of acute leukemias of children. Study of 26 patients].
Michel G; Maraninchi D; Perrimond H; Mascret B; Orsini A; Gastaut JA; Raybaud C; Blaise D; Demeocq F; Sebahoun G
Arch Fr Pediatr; 1986 Dec; 43(10):769-74. PubMed ID: 3548633
[TBL] [Abstract][Full Text] [Related]
70. Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
Aschan J; Ringdén O; Sundberg B; Gahrton G; Ljungman P; Winiarski J
Bone Marrow Transplant; 1991 Feb; 7(2):113-9. PubMed ID: 2049554
[TBL] [Abstract][Full Text] [Related]
71. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.
Helenglass G; Powles RL; McElwain TJ; Lakhani A; Milan S; Gore M; Nandi A; Zuiable A; Perren T; Forgeson G
Bone Marrow Transplant; 1988 Jan; 3(1):21-9. PubMed ID: 3048467
[TBL] [Abstract][Full Text] [Related]
72. Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow.
Bär BM; Schattenberg A; De Man AJ; Hoogenhout MJ; Boezeman J; de Witte T
Bone Marrow Transplant; 1992 Jul; 10(1):45-52. PubMed ID: 1515878
[TBL] [Abstract][Full Text] [Related]
73. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
[TBL] [Abstract][Full Text] [Related]
74. Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.
Cho BS; Lee S; Kim YJ; Chung NG; Eom KS; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Oct; 23(10):1763-70. PubMed ID: 19440217
[TBL] [Abstract][Full Text] [Related]
75. [Prognosis of children with acute myelocytic leukemia after first relapse].
Creutzig U; Ritter J; Boos J; Zimmermann M; Bender-Götze C; Stahnke K
Klin Padiatr; 1998; 210(4):207-11. PubMed ID: 9743954
[TBL] [Abstract][Full Text] [Related]
76. Sixteen adult patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation.
Kodera Y; Morishima Y; Morishita Y; Murase T; Okumura M; Yamada H; Minami S; Kato Y; Ogura M; Nagura E
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():479-85. PubMed ID: 6394811
[TBL] [Abstract][Full Text] [Related]
77. Status of allogeneic bone marrow transplantation in childhood in the GDR.
Zintl F; Hermann J; Fuchs D; Prager J; Müller A; Reiners B; Burger E; Goetz I; Kob D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):389-96. PubMed ID: 2480279
[TBL] [Abstract][Full Text] [Related]
78. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis.
Deeg HJ; Spitzer TR; Cottler-Fox M; Cahill R; Pickle LW
Bone Marrow Transplant; 1991 Mar; 7(3):193-8. PubMed ID: 2059756
[TBL] [Abstract][Full Text] [Related]
79. [Allogeneic bone marrow transplantation in acute myeloid leukemia (AML): results in 14 patients].
Kos M; Hinterberger W; Gadner H; Haas O; Kalhs P; Panzer S; Geissler K; Schwarzinger I; Hinterberger-Fischer M; Neumann E
Wien Klin Wochenschr; 1987 Apr; 99(7):217-22. PubMed ID: 3296468
[TBL] [Abstract][Full Text] [Related]
80. New conditioning regimens for high risk marrow transplants.
Jones RJ; Santos GW
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():15-7. PubMed ID: 2627618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
